Document Detail


Validation of a clinical risk scoring system, based solely on clinical presentation, for the management of pregnancy of unknown location.
MedLine Citation:
PMID:  23040528     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To assess a scoring system to triage women with a pregnancy of unknown location.
DESIGN: Validation of prediction rule.
SETTING: Multicenter study.
PATIENT(S): Women with a pregnancy of unknown location.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Scores assigned to factors identified at clinical presentation, total score calculated to assess risk of ectopic pregnancy (EP) in women with a pregnancy of unknown location, and a proposed three-tiered clinical action plan.
RESULT(S): The cohort of 1,400 women (284 ectopic pregnancies, 759 miscarriages, and 357 intrauterine pregnancies) was more diverse than the original cohort used to develop the decision rule. The recommendations of the action plan were low risk, intermediate risk, and high risk; the recommendation based on the model score was compared with clinical diagnosis. A total of 29.4% intrauterine pregnancies were identified for less frequent follow-up observation, and 18.4% nonviable gestations were identified for more frequent follow-up observation (to rule out an ectopic pregnancy) compared with intermediate risk (i.e., monitor in current standard fashion). For a decision of possible less frequent monitoring, the specificity was 90.8% (89.0-92.6) with negative predictive value of 79.0% (76.7-81.3). For a decision of more intense follow-up observation, the specificity was 95.0% (92.7-97.2). Test characteristics using the scoring system were replicated in the diverse validation cohort.
CONCLUSION(S): A scoring system based on symptoms at presentation has value to stratify risk and influence the intensity of outpatient surveillance for women with pregnancy of unknown location but does not serve as a diagnostic tool.
Authors:
Kurt T Barnhart; Mary D Sammel; Peter Takacs; Karine Chung; Christopher B Morse; Katherine O'Flynn O'Brien; Lynne Allen-Taylor; Alka Shaunik
Related Documents :
20217108 - Fetal genotyping for platelets antigens: a precise tool for alloimmune thrombocytopenia...
3964598 - The obstetric management of non-immunological hydrops.
24351848 - Evaluation of the relationship between high maternal weight and the duration of differe...
2876418 - Intrauterine aplastic anemia and fetal hydrops: a case report.
12202438 - Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnan...
8977408 - Regional differences in the distribution of gonadotropin-releasing hormone cells betwee...
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Validation Studies     Date:  2012-10-03
Journal Detail:
Title:  Fertility and sterility     Volume:  99     ISSN:  1556-5653     ISO Abbreviation:  Fertil. Steril.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-12-31     Completed Date:  2013-04-05     Revised Date:  2014-01-09    
Medline Journal Info:
Nlm Unique ID:  0372772     Medline TA:  Fertil Steril     Country:  United States    
Other Details:
Languages:  eng     Pagination:  193-8     Citation Subset:  IM    
Copyright Information:
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Spontaneous / diagnosis,  epidemiology,  therapy
Adult
Female
Humans
Mass Screening / methods
Models, Statistical
Pregnancy
Pregnancy, Ectopic / diagnosis*,  epidemiology,  therapy*
Risk Factors
Sensitivity and Specificity
Triage / methods*
Grant Support
ID/Acronym/Agency:
K24 HD060687/HD/NICHD NIH HHS; K24HD060687/HD/NICHD NIH HHS; R01 HD036455/HD/NICHD NIH HHS; R01-HD036455/HD/NICHD NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Variance in total levels of phospholipase C zeta (PLC-?) in human sperm may limit the applicability ...
Next Document:  Disclosure of duplicative studies: damned if you don't.